Platelets and mortality in bloodstream infection: a multicenter cohort study
- PMID: 40744277
- PMCID: PMC12377423
- DOI: 10.1016/j.cmi.2025.07.021
Platelets and mortality in bloodstream infection: a multicenter cohort study
Abstract
Objective: The objective of this study was to determine whether thrombocytopenia is independently associated with mortality in patients with bloodstream infections (BSIs) and compare the impact of platelets on mortality with that of white blood cells and neutrophils.
Methods: This retrospective cohort study used the following two U.S. cohorts of patients with BSIs: (1) patients at a multihospital network in the metropolitan Houston, Texas, area between July 01, 2016 and June 17, 2023, and (2) patients in the publicly available Medical Information Mart for Intensive Care (MIMIC)-IV database (2008-2022). We included patients who had their platelets checked in the 48 hours before positive blood culture collection. We created multivariable logistic regression models to determine whether 30-day in-hospital mortality was impacted by the degree of thrombocytopenia (severe [platelets <50 k/μL], moderate [50-99 k/μL], mild [100-149 k/μL], and none [≥150 k/μL]).
Results: We included 21105 patients in the Houston cohort and 2710 in the MIMIC-IV cohort, and 30-day mortality in the Houston cohort was 12.0% (2524/21105) and was significantly associated with the platelet count. After controlling for confounders, the adjusted odds ratio (aOR) for 30-day mortality with severe thrombocytopenia was 4.66 (95% CI, 3.91-5.55); aOR for moderate thrombocytopenia was 2.61 (95% CI, 2.25-3.02); and aOR for mild thrombocytopenia was 1.55 (95% CI, 1.37-1.76), all compared with normal platelet counts (≥150 k/μL). The adjusted odds of death with severe thrombocytopenia were greater than those with neutropenia, leukopenia, or leukocytosis. Results were similar in multiple sensitivity analyses and in the MIMIC-IV cohort.
Discussion: Thrombocytopenia was independently associated with mortality among patients with BSIs. Platelet counts can provide clinicians a readily available way to risk-stratify patients with BSI, and future research should examine the mechanisms by which platelets are protective in BSI.
Keywords: Bacteraemia; Bloodstream infection; Platelet; Sepsis; Thrombocytopenia.
Copyright © 2025 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
References
-
- Verway M, Brown KA, Marchand-Austin A, Diong C, Lee S, Langford B, Schwartz KL, MacFadden DR, Patel SN, Sander B, Johnstone J, Garber G, Daneman N, Prevalence and Mortality Associated with Bloodstream Organisms: a Population-Wide Retrospective Cohort Study, J Clin Microbiol 60(4) (2022) e0242921. - PMC - PubMed
-
- McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P, Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis, Cell Host Microbe 12(3) (2012) 324–33. - PubMed
-
- Wu Y, Zeng Z, Guo Y, Song L, Weatherhead JE, Huang X, Zeng Y, Bimler L, Chang CY, Knight JM, Valladolid C, Sun H, Cruz MA, Hube B, Naglik JR, Luong AU, Kheradmand F, Corry DB, Candida albicans elicits protective allergic responses via platelet mediated T helper 2 and T helper 17 cell polarization, Immunity 54(11) (2021) 2595–2610 e7. - PMC - PubMed
-
- Sun J, Uchiyama S, Olson J, Morodomi Y, Cornax I, Ando N, Kohno Y, Kyaw MMT, Aguilar B, Haste NM, Kanaji S, Kanaji T, Rose WE, Sakoulas G, Marth JD, Nizet V, Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia, Sci Transl Med 13(586) (2021). - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical